Clinical Trial Update: An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy

View source ↗

Summary

Expanded-access update for atezolizumab in locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy, with marketing approval s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Urothelial Carcinoma | Status: APPROVED_FOR_MARKETING